What AI Could Change in Pharmacoepidemiology Research Interviewer: Cristina Ferrario; Interviewee: John Diaz-Decaro, PhD

https://www.medscape.com/viewarticle/what-ai-could-change-pharmacoepidemiology-research-2026a1001085?src= MILAN — At the 42nd annual meeting of the International Society for Pharmacoepidemiology (ISPE), held in Milan from August 29 to September 2, 2026, AI was among the major topics discussed. John Diaz-Decaro, who leads ISPE’s Digital Technology and Artificial Intelligence Special Interest Group, spoke with Univadis Italy, part of the Medscape Professional Network, about some aspects of the increasingly frequent and highly practical interaction between pharmacoepidemiology and AI.